MEMPHIS PHARMACEUTICALS financial statements, including revenue, expenses, profit, and loss

The total revenue of MPCI for the last quarter is 247.14 M EGP, and it's 35.31% higher compared to the previous quarter. The net income of Q2 24 is 58.12 M EGP.